Xtant Medical Holdings Stock Analysis

XTNT Stock  USD 0.89  0.02  2.20%   
Xtant Medical Holdings is undervalued with Real Value of 1.08 and Hype Value of 0.89. The main objective of Xtant Medical stock analysis is to determine its intrinsic value, which is an estimate of what Xtant Medical Holdings is worth, separate from its market price. There are two main types of Xtant Medical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Xtant Medical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Xtant Medical's stock to identify patterns and trends that may indicate its future price movements.
The Xtant Medical stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Xtant Medical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Xtant Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Xtant Medical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Xtant Stock Analysis Notes

About 69.0% of the company outstanding shares are owned by institutional investors. The book value of Xtant Medical was at this time reported as 0.39. The company last dividend was issued on the 14th of February 2018. Xtant Medical Holdings had 1:12 split on the 14th of February 2018. Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana. Xtant Medical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 116 people. For more information please call Sean Browne at 406 388 0480 or visit https://www.xtantmedical.com.

Xtant Medical Holdings Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Xtant Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Xtant Medical Holdings or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Xtant Medical generated a negative expected return over the last 90 days
Xtant Medical has high historical volatility and very poor performance
Xtant Medical has some characteristics of a very speculative penny stock
Xtant Medical Holdings currently holds about 16.5 M in cash with (9.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.
Xtant Medical has a poor financial position based on the latest SEC disclosures
Roughly 69.0% of the company outstanding shares are owned by institutional investors

Xtant Medical Holdings Upcoming and Recent Events

Earnings reports are used by Xtant Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Xtant Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
5th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Xtant Medical Thematic Classifications

In addition to having Xtant Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Drugs Idea
Drugs
Drug manufacturing and delivery

Xtant Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 117.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Xtant Medical's market, we take the total number of its shares issued and multiply it by Xtant Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Xtant Profitablity

Xtant Medical's profitability indicators refer to fundamental financial ratios that showcase Xtant Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Xtant Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Xtant Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Xtant Medical's profitability requires more research than a typical breakdown of Xtant Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14.

Technical Drivers

As of the 25th of April, Xtant Medical maintains the Standard Deviation of 5.09, mean deviation of 3.63, and Market Risk Adjusted Performance of (0.05). Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Xtant Medical Holdings, as well as the relationship between them. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We were able to interpolate thirteen technical drivers for Xtant Medical Holdings, which can be compared to its peers. Please check out Xtant Medical Holdings mean deviation and maximum drawdown to decide if Xtant Medical Holdings is priced fairly, providing market reflects its latest price of 0.89 per share. Given that Xtant Medical Holdings is a hitting penny stock territory we urge to closely look at its jensen alpha.

Xtant Medical Holdings Price Movement Analysis

The output start index for this execution was four with a total number of output elements of fifty-seven. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Xtant Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Xtant Medical Holdings. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Xtant Medical Holdings Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Xtant Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Xtant Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Xtant Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Xtant Medical Predictive Daily Indicators

Xtant Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Xtant Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Xtant Medical Forecast Models

Xtant Medical's time-series forecasting models are one of many Xtant Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Xtant Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Xtant Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Xtant Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Xtant shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Xtant Medical. By using and applying Xtant Stock analysis, traders can create a robust methodology for identifying Xtant entry and exit points for their positions.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana. Xtant Medical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 116 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Xtant Medical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module
When determining whether Xtant Medical Holdings is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Xtant Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Xtant Medical Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Xtant Medical Holdings Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Xtant Stock analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Xtant Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xtant Medical. If investors know Xtant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xtant Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Xtant Medical Holdings is measured differently than its book value, which is the value of Xtant that is recorded on the company's balance sheet. Investors also form their own opinion of Xtant Medical's value that differs from its market value or its book value, called intrinsic value, which is Xtant Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xtant Medical's market value can be influenced by many factors that don't directly affect Xtant Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xtant Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xtant Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xtant Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.